Lunit Expands AI Medical Imaging Solutions in Taiwan & Singapore

Seoul, South Korea-based Lunit will supply its Lunit INSIGHT CXR for chest abnormality detection and Lunit INSIGHT MMG for mammography analysis to the Chung Shan Medical University in Taiwan and Gleneagles Hospital in Singapore, respectively, marking its strategic expansion into the East and Southeast Asian region.

Compared to Taiwan’s current screening program, which relies on low‐dose computed tomography (LDCT) to screen high-risk individuals such as smokers or those with a family history of lung cancer, Chung Shan Medical University (CSMU) aims to validate Lunit INSIGHT CXR for potential integration into the national cancer screening program. The goal is to assess its ability to detect individuals more accurately and efficiently, potentially expanding the screening to a broader group beyond high-risk individuals. This approach could significantly advance Taiwan’s efforts to enhance early detection and improve outcomes in lung cancer screening.

With Lunit’s AI-powered mammography analysis solution, Lunit INSIGHT MMG, Gleneagles Hospital in Singapore plans to enhance screening accuracy and operational efficiency by seamlessly integrating Lunit’s cutting-edge technology into its breast screening workflow.

Our strategic partnerships with Chung Shan Medical University and Gleneagles Hospital Singapore strengthen our presence and open up new opportunities across the market. We believe that these contracts will pave the way for innovative approaches to cancer detection and ultimately improve patient outcomes where it matters most,” said Brandon Suh, CEO of Lunit.

en_GBEnglish (UK)